Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
www.wjpr.net Vol 7, Issue 9, 2018. 571
Gaikwad et al. World Journal of Pharmaceutical Research
“COMPARATIVE STUDY OF EFFECT OF PIPPALI CHURNA AND
ABHAYADI LEHA IN MANAGEMENT OF AMLAPITTA”
Dr. Aniket A. Gaikwad*1
and Dr. Snehalata S. Salunkhe
2
1P.G. Scholar, Department of Kayachikitsa, Bharati Vidyapeeth Deemed To Be University
College and Hospital of Ayurveda, Katraj-Dhankawadi, Pune-43.
2Associate Professor, M.D., Ph.D, Department of Kayachikitsa, Bharati Vidyapeeth Deemed
To Be University College and Hospital of Ayurveda, Katraj-Dhankawadi, Pune-43.
ABSTRACT
Background and Objective: Comparative Study of Effect of Pippali
Churna and Abhayadi Leha in Management of Amlapitta.
Aim:
• To study the comparative effect of Pippali churna and Abhayadi
Leha in the Management of Amlapitta.
Objectives:
• To study Amlapitta in detail.
• To study the efficacy of Pippali churna and Abhayadi Leha in the
management of Amlapitta.
Method: Randomized Control study. 40 patients were selected for the
study and divided into two groups randomly. Group A was given
Pippali Churna with Madhu (1gm) twice in a day with koshna Jala
Group B was given Abhayadi Leha with Madhu (1gm) twice in a day
with koshna Jala Duration of treatment: 21 days with assessment on 0th
, 7th
, 14th
and 21st Day.
This study was carried out in BVU College of Ayurveda & Hospital attached to Bharati
Medical Foundation in Year 2017 and 2018. Results: Comparing all the symptoms of
Amlapitta before and after treatment. Group B is more effective than A. Statistical Analysis:
The Statistical Analysis reveals that Group B is more effective than Group A.
Conclusion:
• The drugs used in both groups can be safely administered in patients with amlapitta.
• Abhayadi Leha is useful in reducing 5 out of 8 symptoms of Amlapitta.
• Pippali churna have better results on 3 out of 8 symptoms as compare to abhayadi leha.
World Journal of Pharmaceutical Research SJIF Impact Factor 8.074
Volume 7, Issue 9, 571-588. Research Article ISSN 2277– 7105
Article Received on
04 March 2018,
Revised on 25 March 2018,
Accepted on 15 April 2018
DOI: 10.20959/wjpr20189-11752
*Corresponding Author
Dr. Aniket A. Gaikwad
P.G. Scholar, Department of
Kayachikitsa, Bharati
Vidyapeeth Deemed To Be
University College and
Hospital of Ayurveda,
Katraj-Dhankawadi, Pune-
43.
www.wjpr.net Vol 7, Issue 9, 2018. 572
Gaikwad et al. World Journal of Pharmaceutical Research
• Hence we conclude that Abhayadi Leha is more effective than Pippali churna in reducing
symptoms of Amlapitta.
• No serious adverse effects were found in any groups.
• The Drug is safe & cost effective.
INTRODUCTION
Amlapitta (Acidity) has become one of the common problems in present era due to change in
lifestyle. It is a pitta dosha dushti disease of the Annavaha strotas (Digestive System) caused
due to mandagni (Poor Apetite) and ama. Amlapitta (Acidity) is mentioned by laghutrayee.
At around 700 A.D Madhavakar describes amlapitta vyadhi separately in Madhavnidan.
Amlapitta (Acidity) also mentioned by Yogratnakar, Bhaishjyaratnavali,
Rasaratnasamuchhaya etc. According to Charak Samhita in Grahani Adhyaya (Cholitis
Chapter) finds similar and identical symptoms of Amlapitta in the purva rupa (Pre
Symptoms) named under the term Shukta paka. Amlapitta may be caused due to excessive
intake of oily, spicy, tinned, frozen, half cooked food, fast food, irregular meal patterns,
habits like alcohol, smoking and psychological stress. i.e. Hurry, Worry and Curry have to
avoid.
Hetusevan increases vidagadha guna of pitta dosha which undergoes fermentation and
become sour (amlibhava) may causes Amlapitta.
There are many drugs available in Samhita for the treatment of Amlapitta (Acidity). Pippali
Chruna and Abhayadi Leha is one of the formulations which are used in Amlapitta (Acidity).
Therefore this study has been undertaken to see the efficacy of Pippali Churna and Abahyadi
Leha in the management of Amlapitta.
Need for Study
Many of individuals are suffering from Amlapitta. To avoid further complications, Amlapitta
have to treat in early stages. Almost all available antacid drugs are liable to have side effects
on body. eg. Ranitidine shows side effects like… Headache, Dizziness.
However many studies have been conducted to evaluate the effectiveness of ayurvedic
formulae on Amlapitta. For better results and convenient medication purpose, comparative
study of effect of Pippali churna and Abhayadi Leha were taken for this study.
www.wjpr.net Vol 7, Issue 9, 2018. 573
Gaikwad et al. World Journal of Pharmaceutical Research
AIM AND OBJECTIVES
Aim
To study the comparative effect of Pippali churna (Ref- Bhaishajya Rat.56/19) and Abhayadi
Leha (Ref- Yogratnakar nidan-35) in the Management of Amlapitta.
Objectives
• To study Amlapitta in detail.
• To study the efficacy of Pippali churna and Abhayadi Leha in the management of
Amlapitta.
Hypothesis
• Pippali churna and Abhayadi Leha are equally effective in the management of Amlapitta.
Null Hypothesis
• Pippali churna and Abhayadi Leha are not equally effective in the management of
Amlapitta.
MATERIALS AND METHODS
1) Pippali churna:- (Bhaishajya Ratnavali 56/16)
No Drug Latin Name Family Part Used Quantity
1 Pippali Piper Longum Piperaceae Fruit 1 Part
2 Madhu Honey --------------- ----------------- As required
Rasa Panchak of Pippali Churna & Madhu
Sr. No. Ingredients Rasa Veerya Vipaka Guna Karma Doshaghanata
1) Pippali Churna Katu Anushna Madhur Guru Deepan, Pachan Pittashamak
2) Madhu Madhur Ushna Madhur Laghu, Ruksha Lekhan Kaphapittahara
Over all Properties of Drug
Rasa:- Katu- Madhur
Veerya:- Ushna
Vipaka:- Madhur
Karma:- Deepan, Pachan
Doshaghanata:- Kaphapittashamak
2) Abhayadi Leha:- (Ref- Yogratnakar nidan-35)
No Drug Latin Name Family Part Used Quantity
1 Haritaki Tarminelia Chebula combretaceae Fruit 1 Part
2 Pippali Piper Longum Piperaceae Fruit 1 Part
www.wjpr.net Vol 7, Issue 9, 2018. 574
Gaikwad et al. World Journal of Pharmaceutical Research
3 Draksha Vitis vinifera linn. Vitaceae Fruit 1 Part
4 Sita (Sugar Cube) Saccharum Officinarum Linn Poaccac Fruit juice 1 Part
5 Dhanvayas Fagonia cretica Linn. Zygophyllaceae Whole plant 1 Part
Rasa Panchak of Abhayadi Leha
Sr No Ingrediants Rasa Veerya Vipaka Guna Karma Doshghnata
1 Haritaki
Kashay
Pancharasa
Pradhana
Ushna Madhur Laghu Ruksha Rechana
Rasayana Tridoshahara
2 Pippali Katu Anushna Madhur Laghu Snigdha
Tikshna
Deepan Medhya
Pachana
Kaphavata
Shamak
3 Draksha Madhur Sheeta Madhur Snigdha
Madhur
Mrudu
Rechaka Vatapittaghna
4 Sita Madhur Sheeta Madhur Snigdha Daha-prashmana Vatapittaghna
5 Dhanvayas Madhur Tikta
Kashay Sheeta Madhur Laghu Snigdha
Deepan Pachana
Ruchikara Vatapittaghna
Over all Properties of Drug
Rasa:- Madhur, Kashay, Tikta
Veerya:- Sheeta
Vipaka:- Madhur
Karma:- Deepan, Pachan, Dahaprashaman, Mrudu Rechak
Doshaghanata:- Vatapittaghna, tridoshahara.
Method of Preparation
All the above mentioned ingredients of Pippali Churna and Abhaydi Leha taken in equal
quantity separately & the churna will be mixed thoroughly. Then each churna is passed
through sieve no. 85 Then churnas are mixed together according to ingredients of Pippali
churna and Abhayadi Leha respectively. Separate pouches of 14gm of are prepard and kept in
air tight container and labeled accordingly.
METHODOLOGY
Type of study
Randomized Comparative clinical study of established drugs.
Method of randomization: by lottery method.
Statistical Test Used
Wilcoxon sign rank W.
www.wjpr.net Vol 7, Issue 9, 2018. 575
Gaikwad et al. World Journal of Pharmaceutical Research
Place of study
The clinical trial carried out at OPD and IPD Of Bharati Vidyapeeth University, Ayurved
Hospital Dhankawadi, Pune-43. Drugs were collected from pune local market.
Standardisation was done at Late Principle B.V. Bhide Foundation, Pune. Authentication
of drugs was done at Botany Department, Pune University.
Sample Size
40 patients were selected for study. The sample size is decided according to prevalence of
Amlapitta. The study divided into 2 groups i.e 20 patients each group.
Selection Criteria
Inclusion Criteria
1) Gender - Male / Female
2) Age - 16 years to 60 years
3) Patient having clinical signs and symptoms of Amlapitta as described in Madhava Nidan.
Ref. (Madhav Nidan 34/2,3)
Avipaka (Suffering from Indigestion)
Klama (Fatigue)
Utklesh(Nausea)
Tikta Udgar (Bitter belching)
Amla Udgar (Sour belching)
Hruddah (Heartburn)
Kanthadaha (Burning sensation in throat)
Aruchi (Disliking of food)
Exclusion Criteria
- Pregnancy / lactation
- Urdhwaga Amlapitta along with other chronic diseases or complications.
- Raktavaman (Blood Vomiting)
- Chronic Alcoholic Patients
- Drug induced Amlapitta
- Patients suffering from acid- peptic disease for more than 2 yrs.
- Patients on any ayurvedic drugs during the last 15 days for same reason.
- Known case of –
www.wjpr.net Vol 7, Issue 9, 2018. 576
Gaikwad et al. World Journal of Pharmaceutical Research
1) Amasayavrana (Gastric Ulcer)
2) Grahanivrana(Duodenal Ulcer)
3) Pittasayaasmari (Cholelithiasis)
4) Tuberculosis
5) Immuno Compromised Diseases
Plan of Work
Particulars Group A Group B
No. of Patients 20 20
Medicine Pippali Churna (In Lehya Form) Abhayadi leha (In Lehya Form)
Anupan Madhu (1gm) Madhu (1gm)
Dose 1 gm 1 gm
Time Pragbhaktakal Pragbhaktakal
Route of Administration Oral Oral
Duration 21 Days 21 Days
Follow Up
Treatment was given for 21 Days duration and follow up were taken on every 7th day from
the commencement of treatment.
Parameters of Assessment
Efficacy Score System
Efficacy of treatment was assessed by adopting scoring methods for the clinical features of
Amlapitta.
Absence of symptoms 0 Grade
Mild degree of symptoms 1 Grade
Moderate degree of symptoms 2 Grade
Severe degree of symptoms 3 Grade
Grading of Lakshanas
1) Avipaka (Suffering from Indigestation) Grade
No Avipaka 0
Avipaka occurs occasionally 2-3 times per week 1
More than 2-3 Ajirna lakshanas like: Anutsaha
Amlamutrapravrutti
Guruta
Glani
2
Avipaka is of severe type which does not subside without medicine & langhana &
which disturbs the routine of patient. 3
2) Klama (Fatigue) Grade
No Klama 0
Occasionally feeling of lassitude without shrama & remains for
sometimes & vanishes. 1
www.wjpr.net Vol 7, Issue 9, 2018. 577
Gaikwad et al. World Journal of Pharmaceutical Research
Lassitude without shrama daily for sometimes. 2
Lassitude without shrama daily for long duration. 3
3) Utklesh (Nausea) Grade
Absent (0) 0
Presence of symptom < 1 time per day 1
Presence of symptom 1-3 time per day 2
Presence of symptom > 4 times per day 3
4) Tikta Udgar (Bitter Belching) Grade
Absent (0) 0
Presence of symptom < 1 time per day 1
Presence of symptom 1-3 time per day 2
Presence of symptom > 4 times per day 3
5) Amla Udgar (Sour Belching) Grade
Absent (0) 0
Presence of symptom < 1 time per day 1
Presence of symptom 1-3 time per day 2
Presence of symptom > 4 times per day 3
6) Hruddaha (Heartburn) Grade
Absent (0) 0
No hearburn (score 1 /7) on all 7 days. 1
No more than mild symptoms overall (score < 3/7) over the 7 days
prior to the visit 2
Moderate to severe heartburn score (> 4/7) on > 2days during a 7 day
period in the treatment 3
7) Kanthadaha (Burning Sensation In Throat) Grade
No daha 0
Daha of moderate degree relieves by milk, cold drink, antacid 1
Daha of severe degree involving kantha & relieved after digestion of
food or vomiting 2
Severe degree of daha involving major areas of abdomen but does not
relieve by any measures mentioned above 3
8) Aruchi (Disliking of food) Grade
Willing towards all bhojya padarth 0
Unwilling towards some specific ahara but less than normal 1
Unwilling for food but could take the meal 2
Unwilling toward unliking foods but not to the other 3
Primary End Point
Improvement in the signs and symptoms of Amlapitta in the patients.
www.wjpr.net Vol 7, Issue 9, 2018. 578
Gaikwad et al. World Journal of Pharmaceutical Research
Secondary End Point
Comparison of effect of Pippali Churna and Abhayadi leha in Amlapitta.
OBSERVATIONS
The 40 patients of Amlapitta were randomly selected from the OPD & IPD of Bharati
Vidyapeeth Ayurveda Hospital (Dept. of Kayachikitsa) with fulfilment of all subjective
criteria.
The OPD patients were given Pippali Churna with Madhu and Abhaydi Leha. They were
thoroughly educated about the method of preparation of the Leha, so that they can prepare
it daily on their own.
The IPD patients were given Pippali churna with Madhu in lehya form and Abhaydi Leha
prepared in the Hospital itself by the trained hospital staff.
Proper follow up was taken after every 7 days and patients were assessed for any change
in the subjective and objective parameters.
In the study, the subjective parameters were tested with the appropriate Statistical Tests to
determine the level of significane of their improvement if any.
1) Avipaka
Showing Statistical analysis for Avipaka symptom
Avipaka Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 2 0 -3.108a 0.002 75.8 Significant
Group B 2 0 -3.624a 0.000 88.2 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Values for Group
A and Group B are less than 0.05 hence we conclude that effect observed in both groups are
significant.
2) Klama
Showing Statistical analysis for Klama symptom
Klama Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 0 0 -.108b 0.914 0.0 NS
Group B 1 0 -2.489a 0.013 70.6 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Value for Group
www.wjpr.net Vol 7, Issue 9, 2018. 579
Gaikwad et al. World Journal of Pharmaceutical Research
A is greater than 0.05 and Group B is less than 0.05 hence we conclude that effect observed
in Group A is not significant while effect observed in Group B is significant.
3) Utklesh
Showing Statistical analysis for Utklesh symptom
Utklesh Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 0 0 .000c 1.000 0.0 NS
Group B 0 0 -2.434a 0.015 85.7 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Value for Group
A is greater than 0.05 and Group B is less than 0.05 hence we conclude that effect observed
in Group A is not significant while effect observed in Group B is significant.
4) Tiktaudgar
Showing Statistical analysis for Tiktaudgar symptom
Tikta Udgar Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 0 1 -1.155b 0.248 -25.0 NS
Group B 1.5 0 -2.969a 0.003 76.0 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Value for Group
A is greater than 0.05 and Group B is less than 0.05 hence we conclude that effect observed
in Group A is not significant while effect observed in Group B is significant.
5) Amlaudgar
Showing Statistical analysis for Amlaudgar symptom
Amla
Udgar
Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 0 0 -2.585a 0.010 70.6 Significant
Group B 2 0 -3.402a 0.001 93.1 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Values for Group
A and Group B are less than 0.05 hence we conclude that effect observed in both groups are
significant.
www.wjpr.net Vol 7, Issue 9, 2018. 580
Gaikwad et al. World Journal of Pharmaceutical Research
6) Hruddaha
Showing Statistical analysis for Hruddah symptom
Hruddaha Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 2 1 -1.578a 0.115 26.9 NS
Group B 1.5 0 -3.363a 0.001 85.2 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Value for Group
A is greater than 0.05 and Group B is less than 0.05 hence we conclude that effect observed
in Group A is not significant while effect observed in Group B is significant.
7) Kanthadaha
Showing Statistical analysis for Kanthadaha symptom
Kanthadaha Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 2 1 -3.581a 0.000 50.0 Significant
Group B 2 0 -3.852a 0.000 85.3 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Values for Group
A and Group B are less than 0.05 hence we conclude that effect observed in both groups are
significant.
8) Aruchi
Showing Statistical analysis for Aruchi symptom
Aruchi Median Wilcoxon Signed
Rank W P-Value % Effect Result
BT AT
Group A 0.5 0 -2.745a 0.006 82.6 Significant
Group B 0 0 -2.539a 0.011 84.2 Significant
Since observations are on ordinal scale, we have used Wilcoxon Signed Rank test to test the
efficacy in Group A and Group B. From above table we can observe that P-Values for Group
A and Group B are less than 0.05 hence we conclude that effect observed in both groups are
significant.
www.wjpr.net Vol 7, Issue 9, 2018. 581
Gaikwad et al. World Journal of Pharmaceutical Research
Comparative Effect of Treatment on
All Parameters for Both Groups
Parameter
Effect of Therapy
Comparative
Efficacy
Group A Group B
Mean %
Effect Remark
Mean %
effect Remark
Avipaka 75.8% Significant 88.2% Significant Equally effective
Klama 0.0 % Not Significant 70.6% Significant Group B
Utklesh 0.0% Not Significant 85.7% Significant Group B
Tiktaudgar 25% Not Significant 76% Significant Group B
Amlaudgar 70.6% Significant 93.1% Significant Group B
Hruddaha 26.9 Not Significant 85.2% Significant Group B
Kanthadaha 50% Significant 85.3% Significant Group B
Aruchi 82.6% Significant 84.2% Significant Equally effective
For comparison between Group A and Group B, we have used Mann Whitney U test. From
above table we can observe that, For Tikta Udgar, Amla Udgar, Hrudadaha, Group B is more
effective than Group B (P-Value is less than 0.05 and Mean rank is more in Group B). For
other symptoms there is no significant difference in Group A and Group B. (P-Value is
greater than 0.05).
Overall effect of treatments on both groups
Mild (50%) effect was seen in Group A and Moderate (60%) effect was seen in Group B.
DISCUSSION
On Basis of Demoghraphic Data
1) Age:- Most of the patient belong to age group 20-40 (65%)
www.wjpr.net Vol 7, Issue 9, 2018. 582
Gaikwad et al. World Journal of Pharmaceutical Research
The probable cause for increasing in this age group may be that the person of this age group
are more exposed towards the changing external environment & mental stress owing to their
socio-economical responsibilities i.e. improper vihar and irregularity in diet. In this age group
pitta Dosha was dominate. It also responsible for the aggravation of the disease process.
2) Gender:- Out of 40 patients Males 14 (35%), Females 26 (65%)
Mejority of the patients were females. In females this may due to faulty diatery habits, and
females not giving priority to there health as they are of the mindset that health and well
being of family comes first.
3) Occupation:- Out of 40 patients Employees 12 (30%) Housewifes 14 (35%)
It was observed that most of house wives were taken Diwasvapna, and Diwasvapa leads to
Agni Mandhya and Tridosha prakopa & then Amlapitta. Service men suffered from mental
stress as Amlapitta is considered as a Psycho-somatic disease.
4) Habitat:- Out of 40 patients 33 (82.5%) were from urban area.
This disease was more found in urban habitat because of improper lifestyle more intake of
junk food & fermented food.
5) Prakruti:- 77.5% patients having Pittapradhan prakruti.
The disease incidence was found to be highest in pitta pradhan prakruti. When they take
Mithya Ahara Vihara all these Doshas get vitiation and produce disease.
6) Agni:- 70% patients having Visham agni.
Most of the patients were having visham agni due to adhyashan, vishamashan, diwaswap, &
improper management of ahar and vihar.
7) Koshtha :- 80% patients having madhyam koshtha.
8) Diet :- 90% patients had mix diet habit.
In this present study, 90% patients had mixed diet group and 10% patient were intaking veg
diet. Maximum number of the patients (90%) have the habit of irregular food intake. Non
vegetarian diet and irregular pattern of food intake lead to Agnimandhya & Tridosha Dusti
which also lead the aggravation of this disease.
9) Manas Bhav:- Most of patient is in stress were having chinta, Most of the patients were
suffering from mental tension and this is responsible for improper digestion which leads to
www.wjpr.net Vol 7, Issue 9, 2018. 583
Gaikwad et al. World Journal of Pharmaceutical Research
Ajirna like condition as mentioned in Ayurvedic classics. For the process of digestion your
Manasika Bhavas should be under control.
10) Guna Pradhanya Aahar:- Out of 40 patients: 30 (75%) Ushna
11 (27.5%) Tikshna Gunatmak Ahar
7 (17.5%) Vidahi
On Basis of Subjective Parameters
1) Avipaka:- On observation Group B (88.2%) and Group A (75.8%) approximately equal
effect seen. Avipaka lakshan reduced due to pittakaphahar, mrudu virechak properties of
Abhayadi Leha and Pippali Churna has katu ras, anushan veerya which improves pachan.
2) Klama:- On observation Group B (70.6%) is more effective than Group A (0.0%) The
symptom decreses due to tridoshahara, vatapittaghana, rasayan and laghu gunatmak property
of Abhayadi Leha.
3) Utklesh:- On observation Group B (85.7%) is more effective than Group A (0.0) The
symptom decreased due to Abhayadi leha is Madhur rsatmak, Sheeta veerya, madhur vipaki
and vatapittghana properties.
4) Tikta udgar:- On observation Group B (75%) is more effective than Group A (25%) The
symptom decreased due to madhur rasatmak, sheet veerya, madhur vipaki and vatapittaghna
property of Abhyadi Leha.
5) Amlaudgar:- On observation Group B (93.1%) is more effective than Group A (70.6%).
The symptom decreased due to deepan, pachan property of both the drugs.
6) Hruddah:- On observation Group B (85.2%) is more effective than Group A (26.9%) The
symptom reduce dure to madhur rasa, sheet veerya, madhur vipak and vatapittaghna
properties of Abhyadi Leha. Pippali has the property of madhur vipaki so it reduces the
symptoms.
7) Kanthadaha:- On observatin Group B (85%) is more effective than Group A (39.6%) The
symptom is reduced due to madhur vipak, pittaghna, madhur rsa and sheeta veerya properties
of Abhaydi Leha. Pippali has the property of madhur vipaki so it reduces the symptoms.
www.wjpr.net Vol 7, Issue 9, 2018. 584
Gaikwad et al. World Journal of Pharmaceutical Research
8) Aruchi:- On observation Group B (84.2%) and Group A (82.6%) approxmetaly equal
effect seen. The symptom is reduced due to tikta kashay rasa, laghu ruksha tikshna gunatmak
and tridoshhara property of Abhyadi Leha. Pippali churna is having propeerties of ushna
veeryatmak, laghutikshna gunatmak kaphavata shamak reduces aruchi.
9) Out of 8 lakshanas Avipaka, Amlaudgar, Aruchi were eviated to greater extend by the
pippali churna as pippali churna having katu rasa, deepan pachan properties it digest ama and
increase agni and improves annavaha strotodusti.
10) Out of 8 lakshanas Klama, Utklesh, Tiktaudgar, Hruddaha, Kanthadaha were eviated to
greater extend by the Abhayadi Leha as Abhayadi Leha having madhur tikta rasa, sheeta
veerya, madhur vipak agnidipan, pittashamak and rechan properties it digest ama and
increase agni and improves annavaha strotodusti.
Thus we can say Abhayadi Leha is showed reduction in grades of maximum subjective
parameters.
Over all effect on both groups
15% marked effect is may be because of chronicity of disease.
Moderate effect were noted on B group because of properties like deepan, Pachan, mrudu
virechan pittashaman properties that construsted with the pittapradhan pathogenesis.
Mild effect i.e 32.5% no effect i.e 15% was observed after treatment.
RESULT
• The clinical trial of Abhaydi leha and Pippali churna is observed to be effective in
reducing the symptoms of Amlapitta.
• The drug Abhaydi leha have significant result on Klama, Utklesh, Tikta-udgar, Hruddah,
Kanthdaha symptoms as compaired to Pippali churna.
• Avipaka, Amla-udgar, Aruchi symptoms there is no significant result found for both
groups.
CONCLUSION
• The purpose of this present study was to compare the efficacy of Pippali churna and
Abhayadi leha in the management of Amlapitta, The cases were selected randomly from
B.V.’s Ayurved Hospital, Pune. This study was designed as Group A- Pippali churna in
lehya form -20 Patients and Group B-Abhayadi leha– 20 Patients.
www.wjpr.net Vol 7, Issue 9, 2018. 585
Gaikwad et al. World Journal of Pharmaceutical Research
• Amlapitta is seen common in middle age people living in urban area having sedentary and
moderate lifestyle.
• Amlapitta is more seen in Visham agni, pitta pradhan prakruti.
• The drugs used in both groups can be safely administered in patients with amlapitta.
• Abhayadi Leha is useful in reducing 5 out of 8 symptoms of Amlapitta.
• Pippali churna have better results on 3 out of 8 symptoms as compare to abhayadi leha.
• Hence we conclude that Abhayadi Leha is more effective than Pippali churna in reducing
symptoms of Amlapitta.
BIBLIOGRAPHY
1. Vagbhatta, Astanga Hrudaya, Hari Sadashiva Shastri Paradakara. Reprint ed. Varanasi:
Chaukhambha Surabharati Prakashana; 2007.
2. MadhavNidan- Madhukosh Vidyotinitika Dvyayopetam-acharya madhavkar pranit
Acharya Shree Yadunandan Upadhyay.
3. Madhava Nidana of Madhava Kara revised & edited by prof. Yadunanda Upadhyaya.
Part-II, Chowkhamba Snaskrit Sansthan, Varanasi.
4. Sri Satyapala, Kashyapa Samhita, with Vidyotinihindi Commentry, Varanasi
Choukambha Sanskrit Sansthan; 2010.
5. Sharma H, editor. Vidyotini. Khila Sthana. Chaukhambha Sanskrit Sansthan; 2009.
Kashyapa, Kashyapa Samhita.
6. Yadavji T, editor. Chikitsa Sthana. Varanasi: Chaukhambha Sanskrit Sansthan; 2001.
Agnivesha, Charaka Samhita, with Ayurveda Dipika Teeka of Chakrapani.
7. Tripathy Brahmanand, Madhavanidana of Madhavakara with Madhukosha vyakhya by
Vijayarakshita and Shrikanthadatta, Varanasi: Chaukhamba Surabharati Prakashana;
2003.
8. Pendy. G., editor Charaka samhita of Agnivesh with Ayurveda Deepika Commentary of
Chakrapanidatta and vidhyotini hindi commentary of Shastri. K. 6th
edition, Varanasi:
Chaukhambha Sanskrit Sansthana, 2000.
9. Agnivesa, Carakasamhita, Chikitsasthana with the commentary of Cakrapanidatta,
Chawkamba Sanskrit Bhavan, Varanasi.
10. Susrutha, Susrutha samhitha, Sootrasthana, verse 42/7-3 commentary by Dalhana,
Chowkamba Krishnadas Academy, Varanasi, 2010.
11. Vagbhata, Astangahrdaya, Sarvangasundara commentary of Arunadutta, Chowkhamba
Orientalia, Varanasi-2007.
www.wjpr.net Vol 7, Issue 9, 2018. 586
Gaikwad et al. World Journal of Pharmaceutical Research
12. Vijaya rakshita and Sreekanta dutta, Madhukosha vyakhya on Madhava nidana,
Chowkamba Sanskrit samsthan, Varanasi, 1993.
13. Pandit Parasurama sasthri, Sarnghdara samhitha by Sarnghdara, prathama khanda
Chawkamba orientalia, 2012.
14. Srikanta murthy K R, Bhavaprakasha of Bhavamishra, Chawkamba Krishnadas
Academy, Varanasi, 2005.
15. Hariprasad tripati, Hareeta samhitha, hindi commentary, Chawkamba krishnadas
Academy, Varanasi, 2005.
16. Kaviraj Ambika dutt Sasthri, Rajeswar Dutt Sasthri, editors, Bhaishajyaratnavali, Hindi
commentary, Chawkamba Sanskrit Samsthan, 7th
edition.
17. Nirmal saxena, Vangasena samhitha Chawkamba Sanskrit series, Varanasi, 2004.
18. Agnivesa, Carakasamhita, with the commentary of Cakrapanidatta- Chawkamba Sanskrit
Bhavan, 2009.
19. Agnivesa, Carakasamhita with the commentary of Cakrapanidatta, Chawkamba Sanskrit
Bhavan, 2009.
20. Susrutha, Susrutha samhitha, commentary by Dalhana, Chowkamba Krishnadas
Academy, Varanasi, 2010.
21. Tikakar Kavirai Atridev Gupt, Astangsangraha, Krishnadas Academy- Varanasi; 2002.
22. Gupt Kaviraj Atridev; Ashtang Sangraha Indu Tika, 2002.
23. Shastri Sudarshana; Madhukosh Sanskrit Commentary of Madhav Nidan, Vidyotini Tika,
2004.
24. Vagbhata, Astangahrdaya, Sarvangasundara commentary of Arunadutta, Chowkhamba
Orientalia, Varanasi, 2007.
25. Gupta K.A., editor, Astanga Sangraha of Vagbhata, reprinted, Varanasi: Krishnadas
Academy, 1993.
26. Agnivesa, Carakasamhita with the commentary of Cakrapanidatta, Chawkamba Sanskrit
Bhavan, 2009.
27. Datta Chakrapani, Charaka Samhita of Charaka with Ayurvedadipika commentary,
Reprint, 2006, Rashtriya Sanskrita Sansthana, New Delhi – 110058.
28. Shastri S., Upadhayya Y, editors Madhava Nidanam of Madhavakara with Madhukosha
Commentary 23rd
edition, Varanasi: Chaukhamb Sanskrit Sansthan, 1994.
29. Datta Chakrapani, Charaka Samhita of Charaka with Ayurvedadipika commentary,
Reprint, 2006, Rashtriya Sanskrita Sansthana, New Delhi – 110058.
www.wjpr.net Vol 7, Issue 9, 2018. 587
Gaikwad et al. World Journal of Pharmaceutical Research
30. Shastri S., Upadhayya Y, editors Madhava Nidanam of Madhavakara with Madhukosha
Commentary 23rd
edition, Varanasi: Chaukhamb Sanskrit Sansthan, 1994.
31. Agnivesha, Charak-samhita, Vidyotini Hindi Commentary by Kashi Nath Shastri and
Gorakha Nath Chaturvedi, Chaukhambha Bharati Academy, Varanasi (India), Reprint
2004.
32. Shri Madhavakara, Madhavanidanam, Madhukosha Sanskrit Commentary on Panch-
nidan Lakshan-1/4, Chaukhambha Surbharati Prakashan, Varanasi (India), 2003.
33. Shastri K.A., editor, Sushruta Samhita of Sushruta, 11th
edition, Varanasi: Chaukhambha
Sanskrit Sansthana, 1997.
34. E Surendran, Rogalakshana samgraha, Amritham ayurveda publishers, Perintalmanna,
2012.
35. Madhav Nidan with Kusum vyakhya by Vaidya Ashutosh Malviya–
shitapittaudardakotha nidanam published by krishnadas Academy, Varanasi, 1st edition
1985.
36. Vijayarakshitha, Sreekanta dutta, Madhava nidana with madhukosha, chawkamba
orientalia, Varanasi, 2005.
37. Susrutha, Susrutha samhitha, Sootrasthana, verse 21/32, commentary by Dalhana,
Srikanta dutta, Chowkamba Krishnadas Academy, Varanasi, 2008.
38. Tiwari PV, Kasyapa samhitha, Khila sthana, 16/42, 2nd
edition, Chawkamba Viswabharati
Varanasi 2002.
39. Priyavat Sharma., editor, Chakradatta, 2nd
edition, Varanasi: Chaukhambha Publishers,
1998.
40. Tiwari PV, Kasyapa samhitha, 2nd
edition, Chawkamba Viswabharati Varanasi 2002.
41. Jagadeeswar Prasad tripati, Chakradutta by Chakrapani, Chawkamba Sanskrit series,
Varanasi, 2005.
42. Indradev tripathi, Yogaratnakara with Vaidyaprabha commentary, Amlapitta chikitsa
sloka 13, Chawkamba krishnadas Academy, Varanasi, 2005.
43. Govindadas, Bhaishajya Ratnavali, Rajeshwaradatta Shastri editor. 18th
edition; Varanasi:
Chaukhambha Sanskrit Samsthan; 2005.
44. Satyapal. B., editor Kasyapa Samhita of Vrddha Jivaka with vidyotini hindi commentary
of Pandit Hemaraja Sharma. 18th
edition, Varanasi: Chaukhambha Sanskrit Bhawan,
2002.
45. Agnivesha, Charaka samhitha, commentary by Chakrapani, Chawkamba Orientalia,
Varanasi, 2003.
www.wjpr.net Vol 7, Issue 9, 2018. 588
Gaikwad et al. World Journal of Pharmaceutical Research
46. Yogatnakar – Vidyotini Hindi Tika Tikakar Ayruvedachrya Shri. Lakshmi Pati Shashtri
Amalpitta Chikitsa- Kwath.
47. Pandit Sharadharacharyas, Sharandhar Samhita, Choukhambha prakashan, Varanasi,
Edition [Reprint]2010.
48. Charaka. Charaka Samhita, Part-1. Sastri K, Chaturvedi G, editors. 2nd
ed. Varanasi:
Chaukhamba Bharti Academy; 2005.
49. Pandit Narahari. Rajanighantu. Tripathi Indradev, editor. 1st ed. Varanasi: Chaukhamba
Krishnadas Academy; 2003.
50. Vaghbhatacharya, Ashtanga Samgraha, Translated by Prof.K.R.Shrikanta Murthy, Vol I
2nd
Edition, Varanasi, Chaukhamba Orientalia, 1998, Tpg:631.
51. Bhavamishra, Bhavaprakasa Nighantu, commentory and edited by Dr. Chunekar K.C,
Dr.Pandey G.S, and Varanasi: Chaukambha Sanskrit Sansthan Reprint, 2004.
52. Susruta, Susruta Samhita, Vol I (Edited with Ayurveda Tattva Sandipika) by Shastri
Kaviraja Ambikadutta, 12th
ed.Varanasi: Chaukhamba Sanskrit Sansthan 2001.
53. Sharma.P.V, Guru Prasad Sharma, Kaiyadeva Nighantu (Pathya apathya vibhodhakar)
1st Edition, Varanasi, Chaukhamba Orientalia and 1979.
54. Vaidya Prasad Ram Gangavishnu Shrikrishnadas, Madanapala Nighantu, Mumbai,
Lakshmi Venkateshwara Steam Press Kalyana Publications, 1954.
55. Charaka Samhita, Part I, Pt. Kashinatha Shastri, Chaukhambha Sanskrit Sansthan
Varanasi, 6th
edn.
56. Sushruta Samhita, by Ambikadatta Shastri, Chaukhambha Sanskrit Santhan Varanasi,
edition-13.
57. Gyanendra Pandey Dravyaguna Vijana Vol 1, 3rd
edition 2005 Chaukhamba Krishna Das
Academy, Varanasi., 411-424.
58. Gupta Kaviraj Atridev, Editor, Hindi Commentary, on Ashtang Samgraha, Krishnadas
Academy Varanasi Reprint 1993, Sutrasthan Chapter 5, Madhu varga.
59. Tripathi Brahmanand, Editor, Charak Chandrika (Hindi Commentary) on Charak
Samhita, Chaukhambha surbharti prakashan.